All Stories

  1. Taste, terroir, and technology

    Article • International Journal of Wine Research, March 2016, Dove Medical Press

    Dr Roger Martin Pinder

  2. Editor’s choice: grapevine genetics are not just for researchers but also important to consumers

    Article • International Journal of Wine Research, April 2013, Taylor & Francis

    Dr Roger Martin Pinder

  3. Editor’s choice: the best of 2011–2012

    Article • Neuropsychiatric Disease and Treatment, February 2013, Taylor & Francis

    Dr Roger Martin Pinder

  4. Editor's choice

    Article • Neuropsychiatric Disease and Treatment, July 2012, Taylor & Francis

    Dr Roger Martin Pinder

  5. More on the benefits of wine for cognitive decline and dementia

    Article • International Journal of Wine Research, September 2011, Taylor & Francis

    Dr Roger Martin Pinder

  6. Alcohol-attributable cancer: fact or fiction?

    Article • International Journal of Wine Research, July 2011, Taylor & Francis

    Dr Roger Martin Pinder

  7. Biodiversity of wine grapes: less than we thought

    Article • International Journal of Wine Research, July 2011, Taylor & Francis

    Dr Roger Martin Pinder

  8. Resveratrol comes of age

    Article • International Journal of Wine Research, July 2010, Taylor & Francis

    Dr Roger Martin Pinder

  9. Editorial Foreword: International Journal of Wine Research

    Article • International Journal of Wine Research, April 2009, Taylor & Francis

    Dr Roger Martin Pinder

  10. Does wine prevent dementia?

    Article • International Journal of Wine Research, February 2009, Dove Medical Press

    Dr Roger Martin Pinder

  11. Is Alzheimer's a preventable disease?

    Article • Annals of General Psychiatry, April 2008, Springer Science + Business Media

    Dr Roger Martin Pinder

  12. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence

    Article • The International Journal of Neuropsychopharmacology, December 2007, Oxford University Press (OUP)

    Professor Anita Riecher-Rössler, Dr Roger Martin Pinder

  13. Treatment of generalized anxiety disorder

    Article • Neuropsychiatric Disease and Treatment, April 2007, Taylor & Francis

    Dr Roger Martin Pinder

  14. Pathological gambling and dopamine agonists: A phenotype?

    Article • Neuropsychiatric Disease and Treatment, February 2007, Taylor & Francis

    Dr Roger Martin Pinder

  15. Restless legs is a medical disorder and can be treated

    Article • Neuropsychiatric Disease and Treatment, December 2006, Taylor & Francis

    Dr Roger Martin Pinder

  16. Fundamentals of Early Clinical Drug Development. From Synthesis Design to Formulation Edited by A. F. Abdel-Magid and Stéphane Caron. John Wiley & Sons, New York. 2006. xv + 323 pp. 16 × 24 cm. ISBN 0-471-69278-6. $99.95.

    Article • Journal of Medicinal Chemistry, November 2006, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  17. Migraine ? a suitable case for treatment?

    Article • Neuropsychiatric Disease and Treatment, September 2006, Dove Medical Press

    Dr Roger Martin Pinder

  18. EDITORIAL FOREWORD

    Article • Neuropsychiatric Disease and Treatment, January 2005, Taylor & Francis

    Dr Roger Martin Pinder

  19. Editorial Foreword

    Article • Neuropsychiatric Disease and Treatment, January 2005, Dove Medical Press

    Dr Roger Martin Pinder

  20. Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?

    Article • Neuropsychiatric Disease and Treatment, January 2005, Taylor & Francis

    Dr Roger Martin Pinder

  21. Wine: A Scientific Exploration, Merton Sandler and Roger Pinder, Taylor and Francis, London, ISBN: 0-415-24734-9

    Article • Stress and Health, September 2004, Wiley

    Dr Roger Martin Pinder

  22. Wine: A Scientific Exploration

    Article • Addiction, September 2004, Wiley

    Dr Roger Martin Pinder

  23. Depression may be associated with hippocampal volume changes and HPA axis dysfunction: is treatment to remission the answer?: review article

    Article • African Journal of Psychiatry, August 2004, African Journals Online (AJOL)

    Dr Roger Martin Pinder

  24. Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?

    Article • Acta Neuropsychiatrica, August 2004, Cambridge University Press

    Dr Roger Martin Pinder

  25. The Application of the Principles of Clinical Drug Development to a Pharmacological Challenge Test of the Serotonergic System

    Article • Journal of Psychopharmacology, March 2004, SAGE Publications

    Dr Roger Martin Pinder

  26. Chairmen’s Introduction

    Article • European Neuropsychopharmacology, September 2003, Elsevier

    Dr Roger Martin Pinder

  27. Drug Design. Cutting Edge Approaches Edited by Darren R. Flower. Royal Society of Chemistry, Cambridge, U.K. 2002. x + 192 pp. 16 × 24 cm. ISBN 0-85404-816-2. £59.50

    Article • Journal of Medicinal Chemistry, March 2003, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  28. Wine

    Article • December 2002, Taylor & Francis

    Dr Roger Martin Pinder

  29. Wine

    Article • December 2002, Taylor & Francis

    Dr Roger Martin Pinder

  30. The identity and parentage of wine grapes

    Article • December 2002, Taylor & Francis

    Dr Roger Martin Pinder

  31. Selecting Methodologies for the Evaluation of Differences in Time to Response Between Antidepressants

    Article • The Journal of Clinical Psychiatry, August 2002, Physicians Postgraduate Press, Inc

    Dr Roger Martin Pinder

  32. Neurotransmitters, Drugs, and Brain Function Edited by R. A. Webster. John-Wiley & Sons, Ltd., Chichester, U.K. 2001. vi + 534 pp. 17 × 25 cm. ISBN 0-47197819-1. $145.00.

    Article • Journal of Medicinal Chemistry, June 2002, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  33. Chemistry and pharmacology of novel antidepressants

    Article • January 2001, Springer Science + Business Media

    Dr Roger Martin Pinder

  34. On the feasibility of designing new antidepressants

    Article • Human Psychopharmacology Clinical and Experimental, January 2001, Wiley

    Dr Roger Martin Pinder

  35. Receptor-Based Drug Design Edited by Paul Leff. Marcel Dekker, Inc., New York. 1998. xi + 382 pp. 16 × 23 cm. ISBN 0-8247-0162-3. $175.00.

    Article • Journal of Medicinal Chemistry, August 1998, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  36. Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats

    Article • Psychopharmacology, January 1998, Springer Science + Business Media

    Dr Roger Martin Pinder

  37. Antidepressants. New Pharmacological Strategies Edited by P. Skolnick. Humana Press, Totowa, NJ. 1997. x + 257 pp. 18.5 × 26 cm. ISBN-0-89603-469-0. $99.50.

    Article • Journal of Medicinal Chemistry, December 1997, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  38. Imipramine and mirtazapine are less effective than expected

    Article • Psychopharmacology, September 1997, Springer Science + Business Media

    Dr Roger Martin Pinder

  39. Chapter 1. Toward Third Generation Antidepressants

    Article • January 1994, Elsevier

    Dr Roger Martin Pinder

  40. Third‐generation antidepressants

    Article • Medicinal Research Reviews, May 1993, Wiley

    Dr Roger Martin Pinder

  41. Mianserin: Pharmacological and clinical correlates

    Article • Nordisk Psykiatrisk Tidsskrift, January 1991, Taylor & Francis

    Dr Roger Martin Pinder

  42. The clinical profile of mianserin

    Article • Nordisk Psykiatrisk Tidsskrift, January 1991, Taylor & Francis

    Dr Roger Martin Pinder

  43. Chapter 6 Neuropeptides and Their Processing: Targets for Drug Design

    Article • January 1987, Elsevier

    Dr Roger Martin Pinder

  44. Chapter 6. Formation and Degradation of Neuropeptides

    Article • January 1986, Elsevier

    Dr Roger Martin Pinder

  45. Chapter 1. Antidepressants

    Article • January 1980, Elsevier

    Dr Roger Martin Pinder

  46. Chapter 1 Antidepressants

    Article • January 1979, Elsevier

    Dr Roger Martin Pinder

  47. Hyperactivity induced by tetrahydroisoquinoline derivatives injected into the nucleus accumbens

    Article • European Journal of Pharmacology, September 1976, Elsevier

    Dr Roger Martin Pinder

  48. Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-l,2,3,4-tetrahydronaphthalene

    Article • Nature, February 1976, Springer Science + Business Media

    Dr Roger Martin Pinder

  49. Malaria. The Design, Use and Mode of Action of Chemotherapeutic Agents

    Article • Journal of Parasitology, August 1975, JSTOR

    Dr Roger Martin Pinder

  50. Dyskinetic phenomena caused by the intrastriatal injection of phenylethylamine, phenylpiperazine, tetrahydroisoquinoline and tetrahydronaphthalene derivatives in the guinea pig

    Article • European Journal of Pharmacology, March 1975, Elsevier

    Dr Roger Martin Pinder

  51. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography

    Article • Nature, July 1974, Springer Science + Business Media

    Dr Roger Martin Pinder

  52. Hallucinogens

    Article • January 1974, Elsevier

    Dr Roger Martin Pinder

  53. Substrate specificity of caeruloplasmin indoles and indole isosteres

    Article • Biochemical Pharmacology, November 1973, Elsevier

    Dr Roger Martin Pinder

  54. 2-Benzylaziridines. Cyclic analogs of amphetamines

    Article • Journal of Medicinal Chemistry, October 1972, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  55. Comparative pharmacology of 5-hydroxytryptamine and its benzofuran, benzo[b]thiophen, and indene isosteres

    Article • Journal of Medicinal Chemistry, July 1971, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  56. 2,5-Dimethoxy-4-methylphenylalanine

    Article • Journal of Medicinal Chemistry, July 1971, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  57. 2-Amino-3-phenyl-1,1,1-trifluoropropanes. Fluorine analogs of amphetamines

    Article • Journal of Medicinal Chemistry, March 1969, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  58. Antimalarials. II. .alpha.-(2-Piperidyl)- and .alpha.-(2-pyridyl)-2-trifluoromethyl-4-quinolinemethanols

    Article • Journal of Medicinal Chemistry, March 1968, American Chemical Society (ACS)

    Dr Roger Martin Pinder

  59. Trifluoromethyl analogs of amphetamine and norephedrine

    Article • Journal of Pharmaceutical Sciences, August 1967, Elsevier

    Dr Roger Martin Pinder